全文获取类型
收费全文 | 36711篇 |
免费 | 2234篇 |
国内免费 | 201篇 |
专业分类
耳鼻咽喉 | 425篇 |
儿科学 | 1152篇 |
妇产科学 | 998篇 |
基础医学 | 3687篇 |
口腔科学 | 1205篇 |
临床医学 | 3181篇 |
内科学 | 7888篇 |
皮肤病学 | 682篇 |
神经病学 | 2202篇 |
特种医学 | 1311篇 |
外国民族医学 | 4篇 |
外科学 | 6757篇 |
综合类 | 849篇 |
现状与发展 | 3篇 |
一般理论 | 27篇 |
预防医学 | 2461篇 |
眼科学 | 1351篇 |
药学 | 2843篇 |
1篇 | |
中国医学 | 265篇 |
肿瘤学 | 1854篇 |
出版年
2023年 | 358篇 |
2022年 | 788篇 |
2021年 | 1644篇 |
2020年 | 985篇 |
2019年 | 1258篇 |
2018年 | 1569篇 |
2017年 | 1138篇 |
2016年 | 1235篇 |
2015年 | 1329篇 |
2014年 | 1682篇 |
2013年 | 2050篇 |
2012年 | 3105篇 |
2011年 | 2996篇 |
2010年 | 1691篇 |
2009年 | 1466篇 |
2008年 | 2223篇 |
2007年 | 2293篇 |
2006年 | 2020篇 |
2005年 | 1789篇 |
2004年 | 1624篇 |
2003年 | 1350篇 |
2002年 | 1179篇 |
2001年 | 364篇 |
2000年 | 310篇 |
1999年 | 281篇 |
1998年 | 197篇 |
1997年 | 132篇 |
1996年 | 141篇 |
1995年 | 107篇 |
1994年 | 95篇 |
1993年 | 77篇 |
1992年 | 147篇 |
1991年 | 160篇 |
1990年 | 128篇 |
1989年 | 123篇 |
1988年 | 105篇 |
1987年 | 97篇 |
1986年 | 88篇 |
1985年 | 117篇 |
1984年 | 78篇 |
1983年 | 52篇 |
1982年 | 53篇 |
1981年 | 55篇 |
1980年 | 41篇 |
1979年 | 50篇 |
1978年 | 40篇 |
1977年 | 34篇 |
1975年 | 35篇 |
1974年 | 36篇 |
1973年 | 35篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
931.
932.
933.
Naveed Khan Muhammad Shoaib Akhtar Barkat Ali Khan Valdir de Andrade Braga Adam Reich 《Archives of Medical Science》2015,11(6):1261-1271
Introduction
Numerous herbal medicines have been recommended for the treatment of different diseases. Achyranthes aspera, Linn. (Family: Amaranthaceae), popularly known as Charchitta or Pitpapra, is commonly used by traditional healers for the treatment of fever, malaria, dysentery, asthma, arterial hypertension, pneumonia, and diabetes. The root extract is well reputed for its insect molting hormonal activity. This investigation was conducted to evaluate the effects of saponins from Achyranthes aspera seeds on the serum lipid profile of albino rats fed a high cholesterol diet.Material and methods
Hypolipidemic, antioxidant and hepatoprotective activities of these saponins were tested as described previously. To determine the mechanism underlying the observed effects, serum antioxidant status was assessed according to ABTS (2,2’-azino-bis-3-ethylbenzo-thiazoline-6-sulfonic acid), superoxide dismutase and ferric ion reducing antioxidant power (FRAP) assays in saponin-treated hyperlipidemic animals. Liver enzyme levels were determined to reveal any possible hepatotoxicity.Results
Four-week oral administration of A. aspera seed saponins produced a significant (p < 0.05) decrease of total cholesterol, total triglycerides and LDL-C and a significant increase of HDL-C level in hyperlipidemic rats. Treatment with A. aspera seed saponins also showed a significant (p < 0.01) improvement of serum antioxidant status in tested animals. No significant hepatotoxicity was produced by such treatment as the serum liver enzyme activity remained unaltered.Conclusions
Saponins from A. aspera seeds possess antihyperlipidemic and antioxidant properties which might lead to improvement of serum lipid profile and blood antioxidant status. Our findings support the folkloric use of this indigenous plant in the treatment of hyperlipidemia. However, its exact mechanism of action remains to be elucidated. 相似文献934.
Miguel Verbitsky Simone Sanna-Cherchi David A. Fasel Brynn Levy Krzysztof Kiryluk Matthias Wuttke Alison G. Abraham Frederick Kaskel Anna K?ttgen Bradley A. Warady Susan L. Furth Craig S. Wong Ali G. Gharavi 《The Journal of clinical investigation》2015,125(5):2171-2178
BACKGROUND. There is frequent uncertainty in the identification of specific etiologies of chronic kidney disease (CKD) in children. Recent studies indicate that chromosomal microarrays can identify rare genomic imbalances that can clarify the etiology of neurodevelopmental and cardiac disorders in children; however, the contribution of unsuspected genomic imbalance to the incidence of pediatric CKD is unknown.METHODS. We performed chromosomal microarrays to detect genomic imbalances in children enrolled in the Chronic Kidney Disease in Children (CKiD) prospective cohort study, a longitudinal prospective multiethnic observational study of North American children with mild to moderate CKD. Patients with clinically detectable syndromic disease were excluded from evaluation. We compared 419 unrelated children enrolled in CKiD to multiethnic cohorts of 21,575 children and adults that had undergone microarray genotyping for studies unrelated to CKD.RESULTS. We identified diagnostic copy number disorders in 31 children with CKD (7.4% of the cohort). We detected 10 known pathogenic genomic disorders, including the 17q12 deletion HNF1 homeobox B (HNF1B) and triple X syndromes in 19 of 419 unrelated CKiD cases as compared with 98 of 21,575 control individuals (OR 10.8, P = 6.1 × 10–20). In an additional 12 CKiD cases, we identified 12 likely pathogenic genomic imbalances that would be considered reportable in a clinical setting. These genomic imbalances were evenly distributed among patients diagnosed with congenital and noncongenital forms of CKD. In the vast majority of these cases, the genomic lesion was unsuspected based on the clinical assessment and either reclassified the disease or provided information that might have triggered additional clinical care, such as evaluation for metabolic or neuropsychiatric disease.CONCLUSION. A substantial proportion of children with CKD have an unsuspected genomic imbalance, suggesting genomic disorders as a risk factor for common forms of pediatric nephropathy. Detection of pathogenic imbalances has practical implications for personalized diagnosis and health monitoring in this population.TRIAL REGISTRATION. ClinicalTrials.gov .FUNDING. This work was supported by the NIH, the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Child Health and Human Development, and the National Heart, Lung, and Blood Institute. NCT00327860相似文献
935.
936.
937.
938.
939.
940.
Risk factors for hospital admission among COVID-19 patients with diabetes: A study from Saudi Arabia
Ayman A. Al Hayek Asirvatham A. Robert Abdullah Bin Matar Ali Algarni Haneen Alkubedan Turki Alharbi Afrah Al Amro Seham A. Alrashidi Mohamed Al Dawish 《Saudi medical journal》2020,41(10):1090
Objectives:To elucidate the risk factors for hospital admission among COVID-19 patients with type 2 diabetes mellitus (T2DM).Methods:This retrospective study was conducted at the Prince Sultan Military Medical City, Riyadh, Saudi Arabia between May 2020 and July 2020. Out of 7,260 COVID-19 patients, 920 were identified as T2DM. After the exclusion process, 806 patients with T2DM were included in this analysis. Patients’ data were extracted from electronic medical records. A logistic regression model was performed to estimate the risk factors of hospital admission.Results:Of the total of 806 COVID-19 patients with T2DM, 48% were admitted in the hospital, 52% were placed under home isolation. Older age between 70-79 years (OR [odd ratio] 2.56; p=0.017), ≥80 years (OR 6.48; p=0.001) were significantly more likely to be hospitalized compared to <40 years. Similarly, patients with higher HbA1c level of ≥9% compared to <7%; (OR 1.58; p=0.047); patients with comorbidities such as, hypertension (OR 1.43; p=0.048), cardiovascular disease (OR 1.56; p=0.033), cerebrovascular disease (OR 2.38; p=0.016), chronic pulmonary disease (OR 1.51; p=0.018), malignancy (OR 2.45; p=0.025), chronic kidney disease (CKD) IIIa, IIIb, IV (OR 2.37; p=0.008), CKD V (OR 5.07; p=0.007) were significantly more likely to be hospitalized. Likewise, insulin-treated (OR 1.46; p=0.03) were more likely to require hospital admission compared to non-insulin treated patients.Conclusion:Among COVID-19 patients with diabetes, higher age, high HbA1c level, and presence of other comorbidities were found to be significant risk factors for the hospital admission. 相似文献